Clinical Trial Update: Role of Strontium Ranelate in Proximal Femur Fragility Fractures. [Phase 4]

View source ↗

Summary

A phase 4 clinical trial update investigates the role of strontium ranelate in proximal femur fragility fractures, including pertrochanteric fractures.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fracture of Pertrochanteric Region
• Fragility Fracture of the Femur

Drugs mentioned

• Strontium ranelate (strontium ranelate)

Snippet

Sponsor: Aga Khan University Hospital, Pakistan | Conditions: Fragility Fracture, Femur; Fracture, Pertrochanteric | Phase 4 | Status: UNKNOWN